Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Appointed CFO
Quarterly results
Appointed director
CC transcript
Credit agrmnt [a]
WALGREEN CO (WAG) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/27/2011 8-K Asset disposition, Quarterly results
Docs: "Walgreen Co. Reports 6.5 Percent Increase in Fourth Quarter Sales; Adjusted Earnings Per Diluted Share Increase to 57 Cents in Quarter, Excluding Gain from Sale of Walgreens Health Initiatives; and GAAP Earnings Per Diluted Share Increase to 87 Cents. ● Fiscal 2011 sales increase 7.1 percent to $72.2 billion, while adjusted earnings per diluted share reach $2.64, excluding after-tax gain from sale of Walgreens Health Initiatives, and GAAP earnings per diluted share reach $2.94 ● Company fills one in five retail prescriptions in America, filling a record 819 million prescriptions in fiscal 2011, an increase of 41 million or 5.3 percent over previous year ● Completes Rewiring for Growth initiative, exceeding goal of $1 billion in annual cost savings ● Returns $2.4 bil..."
06/21/2011 8-K Form 8-K - Current report
01/13/2009 8-K Form 8-K -- Current report
07/17/2008 8-K Asset disposition
Docs: "Underwriting Agreement dated July 14, 2008, by and among the Company and Banc of America Securities LLC and J.P. Morgan Securities Inc., as representatives of the several underwriters named therein",
"Form of 4.875% Note due 2013"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy